FindTrial
Sign In

SC Investigational Needle Sets

DEVICE5 trials

Sponsors

Takeda

Conditions

Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)Healthy VolunteersPrimary Immunodeficiency Diseases (PID)Primary Immunodeficiency Diseases (PIDD)

Phase 1

A Study of TAK-881 and HyQvia in Healthy Adults
CompletedNCT06895967
TakedaHealthy Volunteers
Start: 2025-03-24End: 2025-07-24Updated: 2025-08-19
A Study of TAK-881 With and Without Ramp-Up Dosing in Healthy Adults
CompletedNCT06935266
TakedaHealthy Volunteers
Start: 2025-04-22End: 2025-09-22Updated: 2025-11-03

Phase 3

A Study About the Long-Term Safety of TAK-881 in People With Primary Immunodeficiency Diseases
RecruitingNCT06076642
TakedaPrimary Immunodeficiency Diseases (PID)
Start: 2024-11-04End: 2029-01-15Target: 39Updated: 2025-05-08
A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
RecruitingNCT06747351
TakedaChronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Start: 2025-05-06End: 2028-06-25Target: 59Updated: 2026-01-20

Unknown Phase

Expanded Access to TAK-881 for Children and Teenagers With Primary Immunodeficiency Diseases in the USA
NCT06955793
TakedaPrimary Immunodeficiency Diseases (PIDD)
Updated: 2025-05-02